参考文献/References:
[1] HEATHCOTE E J. Management of primary biliarycirrhosis. The American association for the study ofliver diseases practice guidelines [J]. Hepatology, 2000,31(4):1005-1013.
[2] 王一鹏 , 孙丽梅 , 刘燕敏 , 等 . 抗线粒体抗体 M2 亚型阳性的病毒性肝炎患者血清学指标特征分析 [J].临床肝胆病杂志 , 2015, 31(8):1278-1282.现代检验医学杂志 第 35 卷 第 6 期 2020 年 11 月 J Mod Lab Med, Vol. 35, No. 6, Nove. 202020WANG Yipeng, SUN Limei, LIU Yanmin, et al.Analysis of serological characteristics in viral hepatitispatients with positive AMA-M2[J].Journal of ClinicalHepatology, 2015, 31(8):1278-1282.
[3] 陈韧刚 , 鲁 艳 , 魏三舟 , 等 . 慢性乙型肝炎患者自身抗体与 HBV 基因分型及耐药突变相关因素研究 [J].检验医学与临床 ,2018,15(8):1095-1097.CHEN Rengang, LU Yan, WEI Sanzhou, et al. Studyon the relationship between autoantibody and HBVgenotype and drug resistance mutation in patients withchronic hepatitis B[J]. Laboratory Medicine and Clinic,2018, 15 (8): 1095-1097.
[4] 段爱华 , 温惠萍 , 李静 , 等 . 线粒体抗体 M2 亚型阳性患者中检测血清“两对半”的结果分析 [J]. 山西医药杂志 , 2017, 46(10):1221-1223.DUAN Aihua, WEN Huiping, LI Jing, et al. Analysisof serum “two and a half” in patients with positivemitochondrial antibody M2 subtype [J]. Shanxi MedicalJournal, 2017, 46 (10): 1221-1223.
[5] LI Boan, LIU Jia, HOU Jun, et al. Autoantibodies inChinese patients with chronic hepatitis B: prevalenceand clinical associations [J].World Journal of Gastroenterology,2015,21(1):283-291.
[6] 中华医学会肝病学分会 , 中华医学会消化病学分会 ,中华医学会感染病学分会. 原发性胆汁性肝硬化（又名原发性胆汁性胆管炎）诊断和治疗共识（2015） [J].中华肝脏病杂志 ,2016,24( 1 ): 5-13.Chinese Society of Hepatology, Chinese Medical As-sociation,Chinese Society of Gastroenterology,ChineseMedical Association,Chinese Society of Infectious Dis-eases, Chinese Medical Association.Consensus on thediagnosis and management of primary biliary cirrhosis(cholangitis)[J].Chin J Hepatol,2016,24(1): 5-13.
[7] 中华医学会肝病学分会 , 中华医学会感染病学分会 . 慢性乙型肝炎防治指南 (2015 年更新版 )[J]. 临床肝胆病杂志 ,2015,31(12):1941-1960.Chinese Society of Hepatology and Chinese Societyof Infectious Diseases, Chinese Medical Association.Guidelines for the prevention and treatment of chronichepatitis B (2015 update)[J].Journal of Clinical Hepatology,2015,31(12):1941-1960
[8] 温先勇 , 林江 , 李宝林 . 乙型肝炎患者的自身免疫损伤探讨 [J]. 中国现代医学杂志 ,2015, 25(14):46-49.WEN Xianyong, LIN Jiang, LI Baolin. Autoimmuneinjury in patients with hepatitis B[J]. China Journal ofModern Medicine, 2015, 25(14): 46-49
[9] MICHALSKA Z, STALKE P, WITCZAK-MALINOWS-KA K, et al. Autoimmune reactions in HBV and HCV[J].Medical Science Monitor ,2001,7(Suppl1):175-180.
[10] 谭朝霞 , 唐玉兰 , 高燕 , 等 . 自身抗体在乙型病毒性肝炎和自身免疫性肝炎中的特点分析 [J]. 第三军医大学学报 ,2016,38(15):1762-1766.TAN Zhaoxia, TANG Yulan, GAO Yan, et al. Charac-teristics of autoantibodies in hepatitis B and autoim-mune hepatitis[J].Journal of Third Military MedicalUniversity, 2016,38 (15): 1762-1766
[11] CORPECHOT C,CHAZOUILL?RES O, RA ROUS-SEAU A,et al. A placebo-controlled trial of bezafibratein primary biliary cholangitis[J].New England Journalof Medicine,2018, 378(23):2171-2181.
[12] 周 洋 , 何 寒 青 , 严 睿 , 等 .2005-2017 年 浙 江 省乙型肝炎流行病学特征 [J]. 中国疫苗和免疫 ,2019,25(2):126-130.ZHOU Yang, HE Hanqing, YAN Rui, et al.Epidemiology of hepatitis B in Zhejiang provinceduring 2005-2017 [J]. Chinese Journal of Vaccines andImmunization, 2019,25 (2): 126-130
[13] 孙丽梅 , 王一鹏 , 刘燕敏 , 等 . 抗线粒体抗体 M2 亚型在非原发性胆汁性肝硬化患者中的特点 [J]. 中华肝脏病杂志 ,2015,23(5):343-349.SUN Limei,WANG Yipeng, LIU Yanmin, et al. Differ-ential characteristics of AMA-M2 autoantibody in pri-mary biliary cirrhosis and non-PBC patients[J]. ChineseJournal of Hepatology,2015,23(5):343-349.
[14] 刘红丽 , 杨永峰 . 抗线粒体抗体阴性的原发性胆汁性胆管炎的临床及病理特征 [J]. 临床肝胆病杂志 ,2019,35(3):677-680.LIU Hongli, YANG Yongfeng. Clinical and pathologi-cal features of primary biliary cholangitis with negativeanti-mitochondrial antibody[J]. Journal of ClinicalHepatology, 2019,35 (3): 677-680.
[15] 周晓冬 , 刘会利 , 赵汉东 , 等 . 原发性胆汁性胆管炎患者血清自身抗体及生化指标的特征分析 [J]. 现代检验医学杂志 , 2016, 31(6):32-36.ZHOU Xiaodong, LIU Huili, ZHAO Handong, etal. Characteristic analysis of sera of autoantibodiesand biochemical indexes of patients with primarybiliary cholangitis[J]. Journal of Modern LaboratoryMedicine,2016,31(6):32-36.
[16] 邵体红 , 徐腾达 , 田 然 , 等 . 原发性胆汁性胆管炎血脂异常分布特点 [J]. 中华临床免疫和变态反应杂志 ,2018,12(2):169-172.SHAO Tihong, XU Tengda, TIAN Ran, et al.Distribution of dyslipidemia in primary biliarycholangitis[J]. Chinese Journal of Allergy & ClinicalImmunology , 2018, 12 (2): 169-172.
[17] 李青梅 , 张 玮 . 原发性胆汁性胆管炎 90 例临床特征分析 [J]. 肝脏 , 2019,24(11):1275-1277.LI Qingmei, ZHANG Wei. Clinical characteristics of90 cases of primary biliary cholangitis [J]. ChineseHepatology, 2019, 24 (11): 1275-1277.